Seres Therapeutics

Microbiome Report for Week Ending 4/6/19
Microbiome Report for Week Ending 4/6/19
CP Wire
C3J Therapeutics
bacteriophage
Enterome
Seres Therapeutics
SER-401
Flag link:
Microbiome Report for Week Ending 4/6/19
C3J Therapeutics
bacteriophage
Enterome
Seres Therapeutics
SER-401
Flag link:
Microbiome Report for Week Ending 3/16/19
Microbiome Report for Week Ending 3/16/19
CP Wire
microbiome
Seres Therapeutics
AstraZeneca
stroke
Flag link:
Microbiome Report for Week Ending 3/16/19
microbiome
Seres Therapeutics
AstraZeneca
stroke
Flag link:
AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres
AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres
Endpoints
AstraZeneca
oncology
microbiome
Seres Therapeutics
Flag link:
Microbiome Report for Week Ending 2/9/19
Microbiome Report for Week Ending 2/9/19
CP Wire
microbiome
Seres Therapeutics
Kallyope
Flag link:
Microbiome Report for Week Ending 2/9/19
microbiome
Seres Therapeutics
Kallyope
Flag link:
New CEO axes 30% of Seres’ workforce to refocus on ‘high priority’ late-stage efforts
New CEO axes 30% of Seres’ workforce to refocus on ‘high priority’ late-stage efforts
Fierce Biotech
Seres Therapeutics
layoffs
Flag link:
Microbiome Report for Week Ending 1/19/19
Microbiome Report for Week Ending 1/19/19
CP Wire
microbiome
Seres Therapeutics
Synlogic
Kaleido Biosciences
IPOs
Flag link:
Microbiome Report for Week Ending 1/19/19
microbiome
Seres Therapeutics
Synlogic
Kaleido Biosciences
Flag link:
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
CP Wire
Seres Therapeutics
microbiome
Flag link:
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
Seres Therapeutics
Flag link:
Microbiome Report for Week Ending 10/6/18
Microbiome Report for Week Ending 10/6/18
CP Wire
Rebiotix
Vedanta Biosciences
Seres Therapeutics
LNC Therapeutics
Synlogic
Flag link:
Microbiome Report for Week Ending 10/6/18
Rebiotix
Vedanta Biosciences
Seres Therapeutics
LNC Therapeutics
Synlogic
Flag link:
Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors
Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors
CP WIre
Seres Therapeutics
microbiome
Flag link:
Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors
Seres Therapeutics
Flag link:
Pharma moves beyond Seres hangover in microbiome space
Pharma moves beyond Seres hangover in microbiome space
Biopharma Dive
Seres Therapeutics
microbiome
Flag link:
These five biotech CEOs earned big bucks even as their companies tanked
These five biotech CEOs earned big bucks even as their companies tanked
Stat
biotech
executive pay
Seres Therapeutics
Pacira
Ophthotech
Cempra
Endo International
Flag link:
Seres doubles down on a microbiome do-over as the FDA clears a make-or-break study
Seres doubles down on a microbiome do-over as the FDA clears a make-or-break study
Endpoints
Seres Therapeutics
microbiome
FDA
clinical trials
SER-109
Flag link:
Microbiome work reignites after Seres' initial flame-out
Microbiome work reignites after Seres' initial flame-out
BioPharma Dive
Seres Therapeutics
microbiome
Flag link:

Pages